Related Experiment Videos
Renal tubular acidosis
M Rothstein1, C Obialo, K A Hruska
1Washington University School of Medicine, St. Louis, Missouri.
Endocrinology and Metabolism Clinics of North America
|December 1, 1990
Summary
Renal tubular acidosis (RTA) is a kidney disorder affecting acid excretion. Treatment involves addressing underlying causes, electrolyte imbalances, and alkali therapy to prevent complications.
Area of Science:
- Nephrology
- Internal Medicine
- Biochemistry
Background:
- Renal tubular acidosis (RTA) encompasses disorders of pure tubular damage without glomerular involvement.
- RTA can be hereditary or acquired, stemming from conditions like sickle cell disease, autoimmune disorders, or certain medications.
- Key diagnostic features include hyperchloremic metabolic acidosis, elevated urine pH (>5.5) during acidemia, and absence of obvious causes.
Purpose of the Study:
- To elucidate the pathophysiology and diagnostic criteria of different types of Renal Tubular Acidosis.
- To differentiate between distal (dRTA), proximal (pRTA), and type 4 RTA based on their distinct defects and clinical manifestations.
- To outline the diagnostic approaches and treatment strategies for managing RTA patients.
Main Methods:
- Classification of RTA into three types based on the primary defect: impaired acid excretion (type 1), impaired bicarbonate reabsorption (type 2), and impaired ammonium generation (type 4).
- Utilizing diagnostic tests such as fractional excretion of bicarbonate (FEHCO3-) and urine pH response to acid/alkali loading (e.g., NH4Cl, bicarbonate).
- Clinical assessment of associated conditions like Fanconi syndrome, nephrolithiasis, osteodystrophy, and renal insufficiency.
Main Results:
- Type 2 RTA (pRTA) is rare in adults, often presenting with Fanconi syndrome (aminoaciduria, glycosuria, hyperphosphaturia).
- Type 1 RTA (dRTA) is linked to nephrolithiasis, nephrocalcinosis, osteodystrophy, and growth issues in children.
- Type 4 RTA is typically associated with mild renal insufficiency, often due to diabetes mellitus or interstitial nephritis. Diagnostic tests differentiate RTA types, with pRTA showing FEHCO3- >15% and dRTA <3% after bicarbonate loading.
Conclusions:
- Effective management of RTA requires identifying and treating underlying causes, correcting electrolyte disturbances (hypokalemia, hyperkalemia), and administering alkali therapy.
- Alkali treatment is crucial for preventing and mitigating complications such as nephrolithiasis, bone disease, and growth retardation.
- Understanding the specific RTA type and its associated defects guides personalized treatment strategies for optimal patient outcomes.